375 related articles for article (PubMed ID: 15567770)
1. [Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia].
Lü LX; Guo SQ; Chen W; Li Q; Cheng J; Guo JH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1251-4. PubMed ID: 15567770
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines.
Pae CU; Yoon CH; Kim TS; Kim JJ; Park SH; Lee CU; Lee SJ; Lee C; Paik IH
Int Immunopharmacol; 2006 Apr; 6(4):666-71. PubMed ID: 16504930
[TBL] [Abstract][Full Text] [Related]
3. Effects of antipsychotics on the serum BDNF levels in schizophrenia.
Chen CC; Huang TL
Psychiatry Res; 2011 Oct; 189(3):327-30. PubMed ID: 21320726
[TBL] [Abstract][Full Text] [Related]
4. Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients.
Singh B; Bera NK; Nayak CR; Chaudhuri TK
Cytokine; 2009 Jul; 47(1):1-5. PubMed ID: 19502081
[TBL] [Abstract][Full Text] [Related]
5. The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia.
Song XQ; Lv LX; Li WQ; Hao YH; Zhao JP
Biol Psychiatry; 2009 Mar; 65(6):481-8. PubMed ID: 19058794
[TBL] [Abstract][Full Text] [Related]
6. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
7. Serum TNF-α, IL-10 and IL-2 in schizophrenic patients before and after treatment with risperidone and clozapine.
Ajami A; Abedian F; Hamzeh Hosseini S; Akbarian E; Alizadeh-Navaei R; Taghipour M
Iran J Immunol; 2014 Sep; 11(3):200-9. PubMed ID: 25265997
[TBL] [Abstract][Full Text] [Related]
8. An open comparison of clozapine and risperidone in treatment-resistant schizophrenia.
Flynn SW; MacEwan GW; Altman S; Kopala LC; Fredrikson DH; Smith GN; Honer WG
Pharmacopsychiatry; 1998 Jan; 31(1):25-9. PubMed ID: 9524981
[TBL] [Abstract][Full Text] [Related]
9. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
Zink M; Kuwilsky A; Krumm B; Dressing H
J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
[TBL] [Abstract][Full Text] [Related]
11. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the relationship between the level of cytokine and liver function in patients with clonorchiasis sinensis].
Cai LS; Xiao JY; Xin H; Zhu LX; Chen G; Zhang T; Wang GZ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Feb; 22(1):54-6. PubMed ID: 15283270
[TBL] [Abstract][Full Text] [Related]
13. Investigation of serum cytokine levels and cytokine production in whole blood cultures of paranoid schizophrenic patients.
Kamińska T; Wysocka A; Marmurowska-Michalowska H; Dubas-Slemp H; Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 2001; 49(6):439-45. PubMed ID: 11814238
[TBL] [Abstract][Full Text] [Related]
14. Testosterone in first-episode schizophrenia.
Cesková E; Prikryl R; Kaspárek T
Neuro Endocrinol Lett; 2007 Dec; 28(6):811-4. PubMed ID: 18063925
[TBL] [Abstract][Full Text] [Related]
15. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
[TBL] [Abstract][Full Text] [Related]
16. Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and IL-1 receptor antagonist in schizophrenic patients.
Sirota P; Meiman M; Herschko R; Bessler H
Psychiatry Res; 2005 Apr; 134(2):151-9. PubMed ID: 15840416
[TBL] [Abstract][Full Text] [Related]
17. COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy.
Müller N; Ulmschneider M; Scheppach C; Schwarz MJ; Ackenheil M; Möller HJ; Gruber R; Riedel M
Eur Arch Psychiatry Clin Neurosci; 2004 Feb; 254(1):14-22. PubMed ID: 14991374
[TBL] [Abstract][Full Text] [Related]
18. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia.
Kim JH; Kim SY; Ahn YM; Kim YS
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):301-5. PubMed ID: 16309807
[TBL] [Abstract][Full Text] [Related]
19. Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study.
Gross A; Joutsiniemi SL; Rimon R; Appelberg B
Pharmacopsychiatry; 2004 May; 37(3):119-22. PubMed ID: 15138895
[TBL] [Abstract][Full Text] [Related]
20. Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients.
Kim YK; Myint AM; Verkerk R; Scharpe S; Steinbusch H; Leonard B
Neuropsychobiology; 2009; 59(2):123-9. PubMed ID: 19390223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
